14/06/2023
The WHAM & RAND Report
The WHAM (Women’s Health Access Matters) Report is a series of studies that examine the impact of accelerating sex and gender–based health research on women, their families, and the economy.
As per the report, investing $300 million in women’s health research across just three diseases, can get as much as $13 billion in returns to our economy
Here are few highlights, key findings from The WHAM & RAND Report:
- Before 1993, most testing done in clinical trials and diagnostic and device development was conducted on men.
- Cardiovascular disease is the #1 killer of Women in the US, yet only 1/3 of the participants in clinical trials are female. (Trial subjects: M/M/F)
- 78% of Americans with autoimmune disease are women – it is estimated that 50 million people are afflicted.
- Not Until 2016 were female mice mandated to be included in research by NIH.
- Male animals outnumber females 5 to 1 in pharmacology studies – and 3.7 to 1 in physiology studies.
- 3X Lung Cancer: Lung cancer is the #1 cause of cancer death in women. More women die of lung cancer each year than from breast, ovarian and uterine cancers combined. Non-smoking women are three times more likely than non-smoking men to get it.
- Twice as many women as men suffer from depression in the US. It is the leading cause of disability in women.
- Women are 3/4 of the 5.4 million people suffering from Alzheimer’s disease yet 66% of the animals used in neuroscience research are male or of unreported gender.
- 38% of animal studies researching strokes used females – although these conditions occur more often in women.
- While many brain disorders show substantial differences across gender, animal studies using only males outnumber studies that include females 5.5 to 1.
- A woman’s risk of developing Alzheimer’s disease is almost 2X that of a man, and not just because women live longer.
- Fewer than 45% of animal studies of anxiety and depression use female lab animals, although these disorders are twice as common in women.